GeneNews Reports Loss of $1.3M in Q1 | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular Diagnostics firm GeneNews today said that its first-quarter loss was C$1.3 million (US$1.3 million), or C$.01 per share.

Results for the three months ended March 31 compare to a net loss of C$1.1 million, or C$.02 per share, a year ago.

The Toronto-based company did not disclose other financial information for the quarter, and its quarterly financial filing was not yet available on the SEDAR website, which provides public securities documents for Canadian companies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.

A technology that has the potential to make species go extinct could be used against the Zika virus. 

University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.

If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.